A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression

Cancer Letters

Volumn 328, Issue 2, 2013, Pages 278-284

  Li, Zongmeng ^a   Mou, Haiwei ^a   Wang, Ting ^a   Xue, Jing ^a   Deng, Bo ^a   Qian, Lihua ^a   Zhou, Ye ^b   Gong, Wanghua ^c   Wang, Ji Ming ^c   Wu, Guohao ^d   Zhou, Cheng Fu ^d   Fang, Jing ^a   Le, Yingying ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

Cell migration; Colon cancer cell; FAM3B variant; Metastasis; Slug

Indexed keywords

CELL ADHESION MOLECULE; PROTEIN CDC42; PROTEIN FAM3B 258; TRANSCRIPTION FACTOR SLUG; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; RNA ISOFORMS; TRANSCRIPTION FACTORS;

MUS MUSCULUS;

EID: 84870358887     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.09.026     Document Type: Article

References (42)

1. Xu A.G., Yu Z.J., Jiang B., Wang X.Y., Zhong X.H., Liu J.H., Lou Q.Y., Gan A.H. Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey. World J. Gastroenterol. 2010, 16:960-965.
2. Umar A., Greenwald P. Alarming colorectal cancer incidence trend: a case for early detection and prevention. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1672-1673.
3. Gumbiner B.M., McCrea P.D. Catenins as mediators of the cytoplasmic functions of cadherins. J. Cell Sci. 1993, 17:155-158.
4. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 15:3645-3654.
5. Tsanou E., Peschos D., Batistatou A., Charalabopoulos A., Charalabopoulos K. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res. 2008, 28:3815-3826.
6. Schuhmacher C., Becker I., Oswald S., Atkinson M.J., Nekarda H., Becker K.F., Mueller J., Siewert J.R., Hofler H. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations. Virchows Arch. 1999, 434:489-495.
7. Rosivatz E., Becker I., Bamba M., Schott C., Diebold J., Mayr D., Hofler H., Becker K.F. Neoexpression of N-cadherin in E-cadherin-positive colon cancers. Int. J. Cancer 2004, 111:711-719.
8. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
9. Gemmill R.M., Roche J., Potiron V.A., Nasarre P., Mitas M., Coldren C.D., Helfrich B.A., Garrett-Mayer E., Bunn P.A., Drabkin H.A. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011, 300:66-78.
10. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
11. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses Ecadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
12. Zhu Y., Xu G., Patel A., McLaughlin M.M., Silverman C., Knecht K., Sweitzer S., Li X., McDonnell P., Mirabile R., Zimmerman D., Boyce R., Tierney L.A., Hu E., Livi G.P., Wolf B., Abdel-Meguid S.S., Rose G.D., Aurora R., Hensley P., Briggs M., Young P.R. Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics 2002, 80:144-150.
13. Carnegie J.R., Robert-Cooperman C.E., Wu J., Young R.A., Wolf B.A., Burkhardt B.R. Characterization of the expression, localization, and secretion of PANDER in alpha-cells. Mol. Cell. Endocrinol. 2010, 325:36-45.
14. Cao X., Gao Z., Robert C.E., Greene S., Xu G., Xu W., Bell E., Campbell D., Zhu Y., Young R., Trucco M., Markmann J.F., Naji A., Wolf B.A. Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes 2003, 52:2296-2303.
15. Cao X., Yang J., Burkhardt B.R., Gao Z., Wong R.K., Greene S.R., Wu J., Wolf B.A. Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E543-550.
16. Yang J., Wang C., Li J., Burkhardt B.R., Robert-Cooperman C.E., Wilson C., Gao Z., Wolf B.A. PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells. FEBS Lett. 2009, 583:3009-3015.
17. Robert-Cooperman C.E., Carnegie J.R., Wilson C.G., Yang J., Cook J.R., Wu J., Young R.A., Wolf B.A., Burkhardt B.R. Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function. Diabetes 2010, 59:2209-2218.
18. Li J., Chi Y., Wang C., Wu J., Yang H., Zhang D., Zhu Y., Wang N., Yang J., Guan Y. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Hepatology 2011, 53:1906-1916.
19. Shao Y., Yang S.B., Wang M.W., Wu B.Y., You W.D., Li H. Gene expression profile of human adenocarcinoma by cDNA microarray and clustering. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004, 21:110-115.
20. Huang H., Wu B., Yang S., Shao Y., You W., Wang W., Wang M. Downregulation of PANDER expression in gastric cancer. World Chin. J. Digestol. 2008, 16:1513-1518.
21. Wang O., Cai K., Pang S., Wang T., Qi D., Zhu Q., Ni Z., Le Y. Mechanisms of glucose-induced expression of pancreatic-derived factor in pancreatic beta-cells. Endocrinology 2008, 149:672-680.
22. Price L.S., Collard J.G. Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin. Cancer Biol. 2001, 11:167-173.
23. Yamazaki D., Kurisu S., Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005, 96:379-386.
24. Liotta L.A., Stetler-Stevenson W.G., Steeg P.S. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 1991, 9:543-551.
25. Van der Wurff A.A., Arends J.W., Van der Linden E.P., Ten Kate J., Bosman F.T. L-CAM expression in lymph node and liver metastases of colorectal carcinomas. J. Pathol. 1994, 172:177-181.
26. Ngan C.Y., Yamamoto H., Seshimo I., Ezumi K., Terayama M., Hemmi H., Takemasa I., Ikeda M., Sekimoto M., Monden M. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J. Surg. Oncol. 2007, 15:652-662.
27. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
28. Naik U.P., Eckfeld K. Junctional adhesion molecule 1 (JAM). J. Biol. Regul. Homeost. Agents 2003, 17:341-347.
29. Alves C.C., Carneiro F., Hoefler H., Becker K.F. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front. Biosci. 2009, 14:3035-3050.
30. Uchikado Y., Natsugoe S., Okumura H., Setoyama T., Matsumoto M., Ishigami S., Aikou T. Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2005, 11:1174-1180.
31. Camp E.R., Findlay V.J., Vaena S.G., Walsh J., Lewin D.N., Turner D.P., Watson D.K. Slug expression enhances tumor formation in a noninvasive rectal cancer model. J. Surg. Res. 2011, 170:56-63.
32. Shih J.Y., Yang P.C. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011, 32:1299-1304.
33. Shioiri M., Shida T., Koda K., Oda K., Seike K., Nishimura M., Takano S., Miyazaki M. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer 2006, 94:1816-1822.
34. Rathinam R., Berrier A., Alahari S.K. Role of Rho GTPases and their regulators in cancer progression. Front. Biosci. 2011, 17:2561-2571.
35. Barber M.A., Welch H.C. PI3K and RAC signalling in leukocyte and cancer cell migration. Bull. Cancer 2006, 93:E44-E52.
36. Wennerberg K., Der C.J. Rho-family GTPases: it is not only Rac and Rho (and I like it). J. Cell Sci. 2004, 117:1301-1312.
37. Liu Y., Wang Y., Zhang Y., Miao Y., Zhao Y., Zhang P.X., Jiang G.Y., Zhang J.Y., Han Y., Lin X.Y., Yang L.H., Li Q.C., Zhao C., Wang E.H. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 2009, 63:375-382.
38. Casas E., Kim J., Bendesky A., Ohno-Machado L., Wolfe C.J., Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011, 71:245-254.
39. Chen H., Zhu G., Li Y., Padia R.N., Dong Z., Pan Z.K., Liu K., Huang S. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res. 2009, 69:9228-9235.
40. Brandl M., Seidler B., Haller F., Adamski J., Schmid R.M., Saur D., Schneider G. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J. Cell Sci. 2010, 123:4231-4239.
41. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
42. Wang S.P., Wang W.L., Chang Y.L., Wu C.T., Chao Y.C., Kao S.H., Yuan A., Lin C.W., Yang S.C., Chan W.K., Li K.C., Hong T.M., Yang P.C. P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 2009, 11:694-704.